Atherosclerosis
Volume 205, Issue 2 , Pages 391-395, August 2009

Anti-inflammatory action of apoptotic cells in patients with acute coronary syndromes

Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy

Received 7 May 2008; received in revised form 27 December 2008; accepted 28 December 2008. published online 09 February 2009.

Abstract 

Objectives

Atherosclerotic plaques contain both apoptotic cells and phagocytes. Apoptotic cells are known to exert an anti-inflammatory effect. Little is known on their action in patients with acute coronary syndromes.

Methods and results

We challenged mononuclear phagocytes from the peripheral blood of patients with acute coronary syndromes (n=20) and healthy controls (n=30) with lipopolysaccharide (LPS, 100ng/ml) or peptidoglycan (PGN, 20μg/ml) in the presence or in the absence of apoptotic cells. After 24h, mononuclear phagocytes from patients with acute coronary syndromes produced more TNFα and IL-10 than controls; moreover, they were significantly more susceptible to the anti-inflammatory action of apoptotic cells. Apoptotic cells were more effective in ACS patients with C-reactive protein levels <3mg/l than in patients with CRP levels >3mg/l.

Conclusions

Patients with acute coronary syndromes and low circulating C-reactive protein levels are more sensitive to the anti-inflammatory action of apoptotic cells: this suggests the existence of an enhanced anti-inflammatory feedback circuit, which could contribute to protect from plaque instability.

Keywords: Coronary disease, Apoptosis, Cytokines, Macrophages, Atherosclerosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(09)00004-5

doi:10.1016/j.atherosclerosis.2008.12.042

Atherosclerosis
Volume 205, Issue 2 , Pages 391-395, August 2009